The trial will see healthcare workers given the anti-malarial drug, and will continue after getting approval to proceed from the UK Medicines Agency. The news comes just three weeks after the UK halted the trial after scientists found that there was 'no evidence of benefit' for Covid-19 patients. "We have therefore decided to stop enrolling participants to the hydroxychloroquine arm of the RECOVERY trial with immediate effect." (Image: ITV)However, the MHRA received a request from the University of Oxford on 17 June, to recommence recruitment for the controversial trial. And on 26 June, it was agreed that sufficient measures had been taken to support the safe recruitment of further participants for the trial.

Source: Daily Mirror June 30, 2020 07:14 UTC